Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Up 23.6% in September

Rockwell Medical, Inc. (NASDAQ:RMTI) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 397,500 shares, a growth of 23.6% from the August 31st total of 321,500 shares. Approximately 1.5% of the shares of the stock are short sold. Based on an average trading volume of 416,500 shares, the short-interest ratio is presently 1.0 days.

Hedge Funds Weigh In On Rockwell Medical

Several hedge funds have recently added to or reduced their stakes in RMTI. Armistice Capital LLC grew its position in shares of Rockwell Medical by 22.5% during the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after buying an additional 592,000 shares during the period. Vanguard Group Inc. boosted its stake in Rockwell Medical by 4.0% in the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after acquiring an additional 43,302 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Rockwell Medical by 877.1% during the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares during the period. Finally, SkyOak Wealth LLC grew its holdings in Rockwell Medical by 47.3% during the 1st quarter. SkyOak Wealth LLC now owns 25,110 shares of the company’s stock worth $42,000 after acquiring an additional 8,065 shares during the period. Institutional investors own 23.31% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. HC Wainwright restated a “buy” rating and set a $9.00 price target on shares of Rockwell Medical in a research report on Wednesday, September 11th. StockNews.com upgraded Rockwell Medical from a “sell” rating to a “hold” rating in a report on Wednesday, June 19th.

Rockwell Medical Trading Down 2.9 %

Shares of NASDAQ RMTI opened at $3.66 on Monday. Rockwell Medical has a 1-year low of $1.16 and a 1-year high of $4.57. The company has a 50-day moving average of $2.89 and a two-hundred day moving average of $2.12. The company has a market cap of $113.57 million, a PE ratio of -10.17 and a beta of 1.47. The company has a current ratio of 2.00, a quick ratio of 1.60 and a debt-to-equity ratio of 0.41.

Rockwell Medical (NASDAQ:RMTI) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.05. The firm had revenue of $25.83 million during the quarter, compared to analysts’ expectations of $23.01 million. Rockwell Medical had a negative net margin of 5.06% and a negative return on equity of 6.96%. During the same quarter in the previous year, the company posted ($0.18) EPS. As a group, equities analysts expect that Rockwell Medical will post -0.03 earnings per share for the current fiscal year.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.